Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer

✍ Scribed by J. Lee; Y. H. Im; S. H. Lee; E. Y. Cho; Y. L. Choi; Y. H. Ko; J. H. Kim; S. J. Nam; H. J. Kim; J. S. Ahn; Y. S. Park; H. Y. Lim; B. K. Han; J. H. Yang

• Publisher: Springer
• Year: 2007
• Tongue: English
• Weight: 321 KB
• Volume: 61
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-007-0506-8